Oxytetracycline have the therapeutic efficiency in CD133+ HCC population through suppression CD133 expression by decreasing of protein stability of CD133

Yeonhwa Song(Institut Pasteur Korea), Haeng Ran Seo(Institut Pasteur Korea)
Scientific Reports
October 25, 2018
Cited by 26


Related Papers